Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05442021 · ClinicalTrials.gov registry record · NA
Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
A NA study of Neuropathy, sponsored by NeuFit - Neurological Fitness and Education.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 11
- Study locations
NCT05442021: Completed NA study of Neuropathy, sponsored by NeuFit - Neurological Fitness and Education.
NCT05442021 is a NA study of Neuropathy that has completed, run by NeuFit - Neurological Fitness and Education. The registered enrollment target is 148 participants, below the 180-participant average among 22 other Neuropathy trials with a reported enrollment target (18% lower). The trial reports 11 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05442021, a NA study of Neuropathy, has completed, sponsored by NeuFit - Neurological Fitness and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 11
- Study locations
Study Summary
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.
Primary Outcome
The time in milliseconds that it takes the impulse to travel from the stimulation point at the wrist to the recording electrode.
Conditions Studied
Interventions
- DEVICE TENS
- DEVICE Neubie Direct Current Electrical Stimulation Device
Study Locations (11)
Florida
- APEX Physical Therapy - Cape Coral
- Catalyst Physical Therapy - Clearwater
- APEX Physical Therapy - Fort Myers
New York
- Hands-On Physical Therapy - Astoria
- Hands-On Physical Therapy of Queens Village - Queens Village
- Panetta Physical Therapy & Diagnostics - Ronkonkoma
West Virginia
- Active Fitness Physical Therapy - Oak Hill
- Active Fitness Physical Therapy - Victor
Kentucky
- Diagnostic Solutions - Springfield
Oklahoma
- Courcier Physical Therapy - Edmond
Texas
- Spine & Rehab Specialists - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2023-05-20 |
| Phase | NA |
What the finished NCT05442021 record still lists
NCT05442021 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 180-participant average among 22 other Neuropathy trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which TENS is the first listed.
NCT05442021 lists 11 locations in 6 states (Florida, New York, West Virginia).
Frequently Asked Questions
What is clinical trial NCT05442021 about?
NCT05442021 is a clinical study titled "Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy". This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much...
What is the current status of trial NCT05442021?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2022-08-01. Estimated completion is 2023-05-20.
What conditions does trial NCT05442021 study?
This clinical trial studies the following conditions: Neuropathy.
What interventions are being tested in trial NCT05442021?
The interventions under investigation include: TENS (DEVICE), Neubie Direct Current Electrical Stimulation Device (DEVICE).
Who is sponsoring clinical trial NCT05442021?
This trial is sponsored by NeuFit - Neurological Fitness and Education, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05442021 being conducted?
This trial has 11 study locations across Florida, Kentucky, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05442021's enrollment target sits among peer trials
148 10th of 22 higher than 13 of 22 other Neuropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
RECRUITING · NA
-
Daily Hand-Held Vibration Therapy
RECRUITING · NA
-
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
RECRUITING · NA
-
Improving Autonomic Function and Balance in Diabetic Neuropathy
ACTIVE NOT RECRUITING · NA
-
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
ACTIVE NOT RECRUITING · NA
-
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI